BRR OpCo’s Thermo Fisher Scientific TMO Stock Holding History

BRR OpCo’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,094	Closed	-$956K	–	239
2021 Q1	$956K	Buy	+2,094	New	+$999K	0.11%	95

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BRR OpCo's TMO Position: Q2 2021 in Review

BRR OpCo sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 2,094 shares — an estimated $956K sold.

BRR OpCo first reported a position in TMO in Q1 2021 and held it in 1 quarter. The position peaked at $956K in Q1 2021. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

BRR OpCo reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
BRR OpCo sold 2,094 Thermo Fisher Scientific shares in Q2 2021, an estimated $956K.
BRR OpCo first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 1 quarter.
BRR OpCo's Thermo Fisher Scientific position peaked at $956K in Q1 2021.
2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on BRR OpCo's 13F filing for Q2 2021, filed 9 Aug 2021.